Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1 Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Specimen Handling 6 Colposcopy 5 Human Papillomavirus DNA Tests 4 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Cyclophosphamide 2 polyphenon E 1 human papillomavirus vaccine, L1 type 16, 18 1 adacel 1 Vaginal Smears 1 Tetanus Toxoid 1 Respiratory Function Tests 1 Radiotherapy 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Magnetic Resonance Imaging 1 Loperamide 1 Ipilimumab 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Hydroxyzine 1 Granisetron 1 Electrocardiography 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Papillomavirus Infections × adacel × Clear all

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡